Repetitive Daylight Photodynamic Therapy versus Cryosurgery for Prevention of Actinic Keratoses in Photodamaged Facial Skin: A Prospective, Randomized Controlled Multicentre Two-armed Study

Acta Derm Venereol. 2021 Jan 4;101(1):adv00355. doi: 10.2340/00015555-3717.

Abstract

Actinic keratoses are a chronic condition in ultraviolet-damaged skin, with a risk of progressing to invasive skin cancer. The aim of this study was to investigate the preventive potential of field-directed repetitive daylight photodynamic therapy for actinic keratoses. A randomized trial was performed, including 58 patients with ≥5 actinic keratoses on photodamaged facial skin, who received either 5 full-face sessions of daylight photodynamic therapy within a period of 2 years or lesion-directed cryosurgery. Primary outcome was the mean cumulative number of new actinic keratoses developed between visits 2 and 6 (visit 6 being a follow-up). This outcome was lower after daylight photo-dynamic therapy (7.7) compared with cryosurgery (10.2), but the difference did not reach significance (-2.5, 95% confidence interval -6.2 to 1.2; p=0.18). Several signs of photoageing (fine lines, pigmentation, roughness, erythema, sebaceous gland hyperplasia) were significantly reduced after daylight photodynamic therapy, but not after cryosurgery. Significantly less pain and fewer side-effects were reported during daylight photodynamic therapy than during cryosurgery. This study found that repetitive daylight photodynamic therapy had photo-rejuvenating effects. However, the prevention of actinic keratoses by this therapy could not be proven in a statistically reliable manner.

Keywords: daylight photodynamic therapy; methyl aminolevulinate; photo-rejuvenation; skin ageing; skin cancer prevention; actinic keratoses.

Publication types

  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Aminolevulinic Acid / adverse effects
  • Cryosurgery* / adverse effects
  • Humans
  • Keratosis, Actinic* / diagnosis
  • Keratosis, Actinic* / prevention & control
  • Photochemotherapy* / adverse effects
  • Photosensitizing Agents / adverse effects
  • Prospective Studies
  • Treatment Outcome

Substances

  • Photosensitizing Agents
  • Aminolevulinic Acid